Home › SEC Filings › Current Report (8-K)
Current Report (8-K)
All Current Report (8-K)Annual Report (10-K)Quarterly Report (10-Q)Form 4 Insider TradesSC 13D Beneficial Ownership13F Institutional HoldingsPress ReleasesInsider Cluster ActivityInsider Buy Activity
Theme?
All themes Artificial IntelligenceSemiconductorsQuantum ComputingSpace & SatellitesRobotics & AutomationElectric VehiclesClean & Renewable EnergyBattery & Energy StorageNuclear & FusionCybersecurityCloud & SaaSFintech & PaymentsCrypto & BlockchainGenomics & Gene EditingBiotech & Drug DiscoveryE-commerce & PlatformsStreaming & Digital MediaGaming & EsportsDefense TechCannabis
| Ticker | Type | Sentiment | Impact | Summary | Date |
|---|---|---|---|---|---|
| STRO | 8-K | bullish | 7/10 | Sutro Biopharma reported Q2 2026 revenue of $9.8M (vs $63.7M YoY) and a net loss of $38.5M (EPS -$2.33 vs -$1.35 YoY), a | Aug 12, 2026 |
| ADM | 8-K | neutral | 2/10 | Director Lei Z. Schlitz resigned from the ADM board effective December 31, 2026, due to a voluntary material change in h | Aug 12, 2026 |
| IBATF | 8-K | neutral | 2/10 | International Battery Metals Ltd. appointed Scott Colangelo to its Board of Directors, effective August 11, 2026. Mr. Co | Aug 12, 2026 |
| AADX | 8-K | mixed | 6/10 | Applied Aerospace & Defense reported record Q2 2026 revenue of $167.3M, up 47.4% YoY, but posted a GAAP net loss of $154 | Aug 12, 2026 |
| SAFX | 8-K | bullish | 5/10 | XCF Global (SAFX) announced initial renewable diesel sales to Tartan Oil LLC, a Berkshire Hathaway subsidiary, from its | Aug 12, 2026 |
| MNPR | 8-K | bullish | 6/10 | Monopar Therapeutics reported Q2 2026 net loss of $5.3M ($0.62/share), wider than the $2.5M loss in Q2 2025, driven by i | Aug 12, 2026 |
| HD | 8-K | neutral | 3/10 | Home Depot announced that CEO Ted Decker is taking a temporary medical leave of absence, expected to return within a few | Aug 12, 2026 |
| ADAM | 8-K | bearish | 6/10 | Adamas Trust priced a $90M offering of 9.600% Senior Notes due 2031, with an underwriter option for an additional $13.5M | Aug 12, 2026 |
| DFTX | 8-K | bullish | 7/10 | Definium Therapeutics announced positive topline results from its Phase 3 Voyage study of DT120 ODT in generalized anxie | Aug 12, 2026 |
| KDP | 8-K | neutral | 2/10 | Keurig Dr Pepper Inc. appointed Aaron Alt as an independent board member, effective August 14, 2026, and increased the b | Aug 12, 2026 |
| RMNI | 8-K | neutral | 3/10 | Rimini Street appointed Keith C. Costello as Executive Vice President and Chief Operating Officer, effective August 17, | Aug 12, 2026 |
| SPRB | 8-K | neutral | 6/10 | Spruce Biosciences reported Q2 2026 net loss of $16.2M ($6.68/share) vs $2.1M loss ($3.50/share) in Q2 2025, with no rev | Aug 12, 2026 |
| ZPTA | 8-K | neutral | 3/10 | Zapata Quantum announced a partnership with QuEra, a neutral-atom quantum computing leader, to co-develop applications a | Aug 12, 2026 |
| MDGL | 8-K | neutral | 3/10 | Madrigal Pharmaceuticals appointed John C. Reed, M.D., Ph.D., a top R&D executive from Johnson & Johnson, to its Board o | Aug 12, 2026 |
| FEED | 8-K | bearish | 8/10 | ENvue Medical entered into a $50M committed equity facility (ELOC) with an institutional investor, selling common stock | Aug 12, 2026 |
| CTOR | 8-K | neutral | 2/10 | Citius Oncology appointed Jonathan Peri, Ph.D., J.D., as an independent Class I director, expanding the board to nine me | Aug 12, 2026 |
| NTHI | 8-K | bullish | 7/10 | NeOnc Technologies reported positive Phase 2a topline results for intranasal NEO100 in recurrent IDH1-mutant high-grade | Aug 12, 2026 |
| BLNE | 8-K | bullish | 5/10 | CEO Nicholas Liuzza invested an additional $500,000 via a convertible note that automatically converts into common stock | Aug 12, 2026 |
| SBEV | 8-K | neutral | 3/10 | Splash Beverage Group announced a corporate name change to Endovia Health Sciences, effective August 24, 2026, along wit | Aug 12, 2026 |
| DAIC | 8-K | bearish | 8/10 | CID HoldCo, Inc. (DAIC) received a Nasdaq Staff Determination on August 6, 2026, to delist its common stock for failing | Aug 12, 2026 |
| TOON | 8-K | neutral | 4/10 | Kartoon Studios announced a content distribution deal with Amazon Prime Video to stream its animated series 'HUNDRED ACR | Aug 12, 2026 |
| MSGE | 8-K | bullish | 6/10 | MSGE reported fiscal Q4 2026 results with revenue of $196.3M (+27% YoY) and an operating loss of $8.6M (improved from -$ | Aug 12, 2026 |
| AVLN | 8-K | neutral | 4/10 | Avalyn Pharma reported Q2 2026 results with no revenue and a net loss of $28.9M, widening from $20.2M a year ago due to | Aug 12, 2026 |
| EAT | 8-K | mixed | 6/10 | Brinker International reported Q4 FY2026 results with GAAP EPS of $2.99 (vs $3.09 consensus, a -3.2% miss) and total rev | Aug 12, 2026 |
| IPSC | 8-K | neutral | 5/10 | Century Therapeutics reported Q2 2026 financial results, with a net loss of $34.6M vs. $32.5M in Q2 2025, and cash of $1 | Aug 12, 2026 |
| FLYX | 8-K | bullish | 7/10 | flyExclusive reported Q2 2026 revenue of $111M (+22% YoY) and positive Adjusted EBITDA of $4.2M, marking a $9.4M improve | Aug 12, 2026 |
| APRE | 8-K | neutral | 5/10 | Aprea Therapeutics reported Q2 2026 financial results with a net loss of $3.6M ($-0.07/share), widening from a $3.2M los | Aug 12, 2026 |
| LVO | 8-K | neutral | 4/10 | LiveOne reported Q1 Fiscal 2027 revenue of $19.35M, roughly in line with the prior year's $19.21M, and a net loss per sh | Aug 12, 2026 |
| PODC | 8-K | mixed | 5/10 | PodcastOne reported Q1 Fiscal 2027 revenue of $16.1M (+8% YoY), a record, and Adjusted EBITDA of $1.6M (+172% YoY), also | Aug 12, 2026 |
| DYAI | 8-K | bearish | 7/10 | Dyadic International reported Q2 2026 revenue of $961,138, essentially flat year-over-year (-0.6%), and a net loss of $2 | Aug 12, 2026 |